|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments for: | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Impairment of non-financial assets – net | |||||
| Share of after-tax profit of equity accounted investees | |||||
| Deferred income taxes | |||||
| Investment tax credits | |||||
| Equity-settled share-based payments expense | |||||
| Defined benefit pension plans | |||||
| Other non-current liabilities | |||||
| Derivative financial assets and liabilities – net | |||||
| After-tax gain on disposal of discontinued operations | |||||
| Gain on remeasurement of previously held equity interest | |||||
| Other | |||||
| Changes in non-cash working capital | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Business combinations, net of cash acquired | |||||
| Property, plant and equipment expenditures | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Advance payments for property, plant and equipment | |||||
| Intangible assets expenditures | |||||
| Net payments to equity accounted investees | |||||
| Dividends received from equity accounted investees | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net repayment of borrowing under revolving credit facilities | |||||
| Proceeds from long-term debt | |||||
| Repayment of long-term debt | |||||
| Repayment of lease liabilities | |||||
| Net proceeds from the issuance of common shares | |||||
| Repurchase and cancellation of common shares | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of foreign currency exchange differences on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...